Á¦108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ(1ÀÏÂ÷) : 2022-11-11±³À°ÀÏÀÚ : 2022-11-11
±³À°Àå¼Ò : ¼Ûµµ ÄÁº¥½Ã¾Æ
±³À°ÁÖÁ¦ :
(¿ÀÇÁ¶óÀÎ) Á¦108Â÷ ´ëÇÑ»êºÎÀΰúÇÐȸ Çмú´ëȸ(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ»êºÎÀΰúÇÐȸ
´ã´çÀÚ : À¯´ÙÀÎ
¿¬¶ôó : 02-3445-2262
À̸ÞÀÏ :
office@ksog.org ±³À°Á¾·ù : »êºÎÀΰúÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 1800¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
ÀÎõ±¤¿ª½Ã±³À°½Ã°£ : 31 ½Ã°£ 38ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í Àü°øÀÇ 90,000¿ø, Àü¹®ÀÇ 120,000¿ø, ºñȸ¿ø(¿¬±¸¿ø,°£È£»ç) 100,000¿ø, ºñȸ¿ø 150,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11-11 Room 1 10:00~10:03 Àλ縻_ȸÀå´Ô ¹ÚÇü¹«(´ëÇÑ»êºÎÀΰúÇÐȸ ȸÀå)
±âŸ 11-11 Room 1 10:03~10:06 Àλ縻_ÀÌ»çÀå´Ô ¹ÚÁß½Å(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀå)
±âŸ 11-11 Room 1 10:06~10:11 °ø·ÎÆÐ ¼ö¿©½Ä ¹ÚÇü¹«(´ëÇÑ»êºÎÀΰúÇÐȸ ȸÀå)
±âŸ 11-11 Room 1 10:11~10:15 ¸í¿¹È¸¿øÀ§ÃË½Ä ¹ÚÁß½Å(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀå)
±âŸ 11-11 Room 1 10:15~10:20 AOFOG È«º¸ ¿µ»ó ()
±³À°½Ã°£ 11-11 Room 1 10:20~10:30 (¸ðüžÆÀÇÇÐ) Metabolic dysfunction-associated fatty liver disease and subsequent development of adverse pregnancy outcomes À̽¹Ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 1 10:30~10:40 (»ý½Ä³»ºÐºñÇÐ) Risk of type 2 diabetes is increased in nonobese women with polycystic ovary syndrome: National Health Insurance Service-National Sample Cohort data ·ù±âÁø(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-11 Room 1 10:40~10:50 (ºÎÀÎÁ¾¾çÇÐ) Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum ¹Ú¼öÁø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 1 10:50~11:00 (ÀϹݺÎÀΰúÇÐ) Development and validation of a prediction model for bothersome stress urinary incontinence after prolapse surgery ¿À¼ö¹Î(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-11 Room 1 11:00~11:20 The Red Line Initiative: women as weapons as war Jeanne Conry(FIGO USA)
±³À°½Ã°£ 11-11 Room 1 11:20~11:40 Fusion imaging using US and MRI: preliminary experience from the LUMIERE research platform Laurent Salomon(Paris Descartes University France)
±³À°½Ã°£ 11-11 Room 1 11:40~12:00 Cancer genetics for the general Gynecologist David Cohn(The Ohio State University USA)
±³À°½Ã°£ 11-11 Room 1 12:00~12:20 Mitochondrial replacement therapy in reproductive medicine Shoukhrat Mitalipov(Oregon Health & Science University USA)
Åä·Ð 11-11 Room 1 12:20~12:40 Discussion ()
±³À°½Ã°£ 11-11 Room 1 12:40~13:10 HPV¹é½Å ÃÖ½ÅÁö°ß : Paradigm Shift & Key Data Update ¹Î°æÁø(°í·ÁÀÇ´ë)
ÈÞ½Ä 11-11 Room 1 13:10~13:40 Lunch ()
±³À°½Ã°£ 11-11 Room 1 13:40~14:00 ºÐ¸¸ ÀÎÇÁ¶ó À¯Áö ±âº» ¼ö°¡ °³¼³ ȲÁ¾À±(°¿øÀÇ´ë)
±³À°½Ã°£ 11-11 Room 1 14:00~14:20 Áú°Ã³Ä¡·á ÀûÀÀÁõ ¹× Ƚ¼öÁ¦ÇÑ °³¼± - È®ÀÎ ÇÊ¿ä À̱âö(À̱âö ¿©¼ºÀÇ¿ø)
Åä·Ð 11-11 Room 1 14:20~14:50 Panel Discussion ȲÁ¾À± / À̱âö / Á¶¿µ´ë(°¿øÀÇ´ë / À̱âö ¿©¼ºÀÇ¿ø / º¸°Çº¹ÁöºÎ)
±³À°½Ã°£ 11-11 Room 2 08:00~08:15 °³¿ø°¡¿¡¼ÀÇ º¸Çè ¼ö°¡ û±¸ ÆÁ ±è±Ý¼®(´ÙÁ¤»êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 2 08:15~08:30 ³ÀÓ È¯ÀÚ Áø·á ¼ö°¡ û±¸ ÁÖâ¿ì(¸¶¸®¾Æº´¿ø)
±³À°½Ã°£ 11-11 Room 2 08:30~08:45 »ê°ú ÃÊÀ½ÆÄ Áø·á ¼ö°¡ û±¸ ¼³ÇöÁÖ(°µ¿°æÈñ´ë)
±³À°½Ã°£ 11-11 Room 2 08:45~09:00 ºÎÀÎ¾Ï ¹× ¼ö¼ú ½Ã Áø·á ¼ö°¡ û±¸ ÃÖÁß¼·(ÇѾçÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 13:20~13:30 ȯÀÚÁ᫐ ÀÇ·á±â¼ú ÃÖÀûÈ ¿¬±¸»ç¾÷ ¼Ò°³ Á¶¼ÛÈñ(PACEN)
±³À°½Ã°£ 11-11 Room 2 13:30~13:40 Ãʱâ Àڱ󻸷¾Ï¿¡¼ °¨½Ã¸²ÇÁÀýŽ»ö°ú °í½ÄÀû ¸²ÇÁÀýÀýÁ¦¼úÀÇ ºñ±³ ¿¬±¸ ±è»ó¿î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 13:40~13:50 ±¹³» °íÀ§Çè »ê¸ðÀÇ ÀÓ»óÀû Ư¼º ¹× ÁÖ»ê±â ¿¹ÈÄ ºÐ¼®À» ÅëÇÑ °íÀ§Çè »ê¸ð °ü¸® ¸ðµ¨ °³¹ß ¿À¼ö¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 13:50~14:00 Áú½ÄºÐ¸¸ ÀÓ»êºÎÀÇ »ê¿å±â °¨¿°°ú ½Å»ý¾ÆÀÇ ÁÖ»ê±â °¨¿°À» ¿¹¹æÇϱâ À§ÇÑ Áø·áÁöħ È®¸³ À̽¹Ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 14:00~14:10 »êºÎÀΰú Àü°øÀÇ ±³À° ¼ö·Ãü°è °³¼±¹æ¾È ¿¬±¸ È«¼øö(°í·ÁÀÇ´ë)
Åä·Ð 11-11 Room 2 14:10~14:20 ÁúÀÇÀÀ´ä ()
ÈÞ½Ä 11-11 Room 2 14:20~14:25 Break time ()
±³À°½Ã°£ 11-11 Room 2 14:25~14:50 »êºÎÀΰú ºÐ¾ß ȯÀÚÁ᫐ Àӻ󿬱¸ÀÇ °³¼± ¹× ¹ßÀü¹æÇâ Á¶¼ÛÈñ±è»ó¿î¿À¼ö¿µÀ̽¹ÌÈ«¼øö(PACEN¿¬¼¼ÀǴ뼺±Õ°üÀǴ뼿ïÀÇ´ë°í·ÁÀÇ´ë)
ÈÞ½Ä 11-11 Room 2 14:50~15:10 Coffee Break ()
±³À°½Ã°£ 11-11 Room 2 15:10~15:40 Èñ¼Ò¡¤±ä±ÞµµÀÔ ÇÊ¿ä ÀÇ·á±â±â °ø±Þ »ç¾÷ ÀÌÈ¿¼®(Çѱ¹ÀÇ·á±â±â¾ÈÀüÁ¤º¸¿ø °ø±Þ°ü¸®ÆÀ)
±³À°½Ã°£ 11-11 Room 2 15:40~16:40 °¡¸íÁ¤º¸ °áÇÕÁ¦µµ ¼³¸íȸ Á¶±Ôµ¿ ºÎ¿¬±¸À§¿ø(±¹¹Î°Ç°º¸Çè°ø´Ü)
±âŸ 11-11 Room 2 16:40~16:45 Àλ縻 ¹ÚÁ߽ŹæÀº¿Á(´ëÇÑ»êºÎÀΰúÇÐȸ ÀÌ»çÀåÁúº´°ü¸®Ã» °úÀå)
±âŸ 11-11 Room 2 16:45~16:55 Á¤Ã¥¿¬±¸¿ë¿ª ¼Ò°³ Á¶±ÝÁØ ±³¼ö(°í·ÁÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 16:55~17:10 ÀӽźΠCOVID-19 °¨¿° ¹×¹é½ÅÁ¢Á¾ ³ª¼ºÈÆ(°¿øÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 17:10~17:25 ±¹³» ÀӽźΠCOVID-19 ¹é½ÅÁ¢Á¾ ÀÌ»ó¹ÝÀÀ ÇöȲ (Àüȼ³¹® °á°ú) ¼º¿øÁØ(°æºÏÀÇ´ë)
±³À°½Ã°£ 11-11 Room 2 17:25~17:40 ÀӽŠÁß COVID-19 ¹é½ÅÁ¢Á¾¿¡ ´ëÇÑ Àνĵµ Á¶»ç °íÇö¼±(°¡Å縯ÀÇ´ë)
±âŸ 11-11 Room 4 08:00~08:05 Àλ縻 ¿øÇý¼º(´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ȸÀå)
±³À°½Ã°£ 11-11 Room 4 08:05~08:25 žÆÀÌ»ó ÀÌ¿ÜÀÇ ÃʱâÀӽŠÃÊÀ½ÆÄÀÌ»ó ¼Ò°ßÀÇ ´ëó¹ý ȲÇѼº(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 11-11 Room 4 08:14~08:45 FNT, IT, NB, ±×¸®°í NIPT ½ÅÀçÀº(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 11-11 Room 4 08:23~09:05 ´ÙÅÂÀӽſ¡¼ À¶¸ð¸·¼º°ú ¾ç¸·¼ºÀÇ °áÁ¤ À̽¹Ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 4 09:05~09:25 Áø´Ü °¡´ÉÇÑ ÅÂ¾Æ ±¸Á¶Àû ÀÌ»ó ¼º¿øÁØ(°æºÏÀÇ´ë)
Åä·Ð 11-11 Room 4 09:25~09:30 Discussion ()
±³À°½Ã°£ 11-11 Room 4+5+6 15:10~15:40 Ultrasonic vs Advanced Bipolar(Feat, Voyant intelligence energy device) ±èÈñ½Â ±³¼ö(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 11-11 Room 4+5+6 15:40~16:00 Æó°æ ¿©¼º¿¡¼ STEAR(Tibolone)°¡ °¡Áö´Â ÀåÁ¡ ÀÌÁö¿µ ±³¼ö(°Ç±¹´ëº´¿ø)
±³À°½Ã°£ 11-11 Room 4+5+6 16:00~16:20 ºñÀÜ¢ç, Àڱ󻸷ÁõÀÇ »õ·Î¿î Æз¯´ÙÀÓÀÇ Á߽ɿ¡ ¼´Ù! ±è½½±â(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 4+5+6 16:20~16:40 Fine details for Fetal Ultrasonographic diagnosis ±è¿µ³² ±³¼ö(ºÎ»ê¹éº´¿ø)
±³À°½Ã°£ 11-11 Room 4+5+6 16:40~17:00 Implementation of AI in Fetal US: present and future ±ÇÀÚ¿µ ±³¼ö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-11 Room 5 08:00~08:20 Basic performance and risk in trocar insertion ±èÅÂÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 5 08:20~08:40 Practical point of laparoscopic suturing and instrumentation ±èÁ¤½Ä(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 11-11 Room 5 08:40~09:00 Which one is better? Monopolar vs. bipolar instrument ÀÌÀÎÇÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 11-11 Room 5 09:00~09:20 Clinical practice in hysteroscopy ¹Ú¼Ò¿¬(ÀÌÈÀÇ´ë)
Åä·Ð 11-11 Room 5 09:20~09:40 Discussion ()
±âŸ 11-11 Room 6 07:55~08:00 °³È¸»ç ÀÌÅÃÈÄ(´ëÇÑ°¡Àӷº¸Á¸ÇÐȸ ȸÀå)
±³À°½Ã°£ 11-11 Room 6 08:00~08:20 Fertility preservation : Global view with current guidelines of international societies ±è¼º¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 11-11 Room 6 08:20~08:40 Public sperm bank in Korea ¹Ú³²Ã¶(ºÎ»êÀÇ´ë ºñ´¢±â°ú ¸í¿¹±³¼ö/Çѱ¹°ø°øÁ¤ÀÚÀºÇ࿬±¸¿ø ÀÌ»çÀå)
±³À°½Ã°£ 11-11 Room 6 08:40~09:00 Donor oocyte bank : worldwide status and application in Korea ÀÌ´Ù¿ë(¿ï»êÀÇ´ë)
±³À°½Ã°£ 11-11 Room 6 09:00~09:20 Gestational surrogacy in Korea: legal, social and ethical issues ÀÌÀÏÇÐ(¿¬¼¼ÀÇ´ë ÀÇ·á¹ýÀ±¸®Çаú)
Åä·Ð 11-11 Room 6 09:20~09:30 Q&A ()
±³À°½Ã°£ 11-11 Room 7 08:00~08:10 Exposure of PM2.5 and metabolic dysfunction during pregnancy via personalized measurement of PM2.5 in South Korea: A multi-center prospective cohort, APPO (air pollution on pregnant women) study Á¤¿¬¼º(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 08:10~08:20 Machine learning-based prediction model for spontaneous preterm birth in singleton pregnancies using midtrimester cervical elastographic parameters Á¤À±Áö(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 08:20~08:30 Melatonin restores the M1-biased macrophage to prevent preterm birth in a murine model with intrauterine inflammation À¯³ª°æ(Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 08:30~08:40 Comparison Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antibody levels in cord blood after vaccination with after COVID-19 infection during pregnancy ÀÌÁö¼±(¼¿ï´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 08:40~08:50 Reduction of contraction by micro-electrical stimulation of human uterine smooth muscle tissue obtained from C-section ÃÖÀº»ù(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 08:50~09:00 The novel nanocarrier for treatment of preterm delivery ±èÇý¿¬(°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 09:00~09:10 Study on the relationship between Vitamin D-binding protein (VDBP) rs7041 genotype and Preterm labor ¼Çö°æ(°æ»ó´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 09:10~09:20 The Cellular and Molecular Responses to Triphenyl phosphate in Human uterine myometrium: Implications on Preterm Labor ¿À¼Ò¶ó(µ¿¾Æ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 09:20~09:30 Which placental pathologic findings affect perinatal and infant long-term outcomes of preterm-delivered intrauterine growth restriction baby? Á¤¿µÀº(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 09:30~09:40 Effects of Fetal Images Produced by Virtual Reality on Maternal-fetal Attachment: Randomized Clinical Trial ½ÅÇϸ²(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 15:10~15:20 The relationship between the success rate of External cephalic version and Breech progression angle at the outpatient clinic: a single center experience ¼ºÁö¼ö(Áß¾Ó´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 15:20~15:30 Neonatal outcomes of previable preterm births according to the delivery indications ±èÈ¿Á¤(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 15:30~15:40 Can common carotid artery ultrasonography help in screening high-risk pregnant women? ¹®Çý¿¬(°í·ÁÀÇ´ë ¾È»êº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 15:40~15:50 Risk factors for postpartum endometritis after uterine artery embolization for postpartum hemorrhage ÀÌÀºÁø(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 15:50~16:00 ÀӽŠ½Ã±â¿¡ µû¸¥ Àӽżº ´ç´¢ ¿¹Ãø ¸ðµ¨ À̼±ÀÇ(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 16:00~16:10 Distribution of phthalates in pregnant women-matching biological father pairs and thyroid hormone concentrations in cord sera ÀÌÇöÁö(ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 16:10~16:20 Serum vitamin D can be used as biomarkers in pregnancy indused hypertension? °¹ÎÁö(°æ»ó´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 16:20~16:30 Machine learning approach for the prediction of dystocia ÀÌÇѳª(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 16:30~16:40 The umbilical cord blood microRNA profiles in spontaneous preterm birth and term birth Æí½Â¿¬(°µ¿°æÈñ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 16:40~16:50 The effect of maternal body mass index on 100gm oral glucose tolerance test profile in gestational diabetes mellitus with singleton and twin pregnancies ÀÌÀ¯¹Î(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 16:50~17:00 Effect of hypoxemia on Preterm birth and Small for gestational age in SARS CoV-2 infection during singleton pregnancy In South Korea ±èÀÇÇõ(±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 17:00~17:10 Maternal risk factors for recurrent small-for-gestational age at term neonates in South Korea Á¶ÀºÇý(ÀÎÁ¦ÀÇ´ë ºÎ»ê¹éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 17:10~17:20 A comparison of anxiety and depression in postpartum women ±èº¸¶÷(Á¦ÁÖ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 7 17:20~17:30 The relationship between maternal factors and neonatal factors in an unsuccessful vaginal delivery ¹Ú¼ÒÇö(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 08:00~08:10 Serially collected circulating tumor DNA (ctDNA) in BRCA mutated ovarian patients receiving PARP inhibitor: implication for resistance mechanism and post-progression therapy ±èÀ¯³ª(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 08:10~08:20 The Impact of Postoperative Residual Disease in Patients with Primary Epithelial Ovarian Cancer: A Systematic Review and Meta-Analysis in the Era of Targeted therapy era ±èÁöÇö(±¹¸³¾Ï¼¾ÅÍ)
±³À°½Ã°£ 11-11 Room 8 08:20~08:30 The impact of enhanced recovery after surgery (ERAS) on perioperative and oncological outcomes in ovarian cancer surgery ÇÏÈñÀº(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰúr)
±³À°½Ã°£ 11-11 Room 8 08:30~08:40 Effect of subcutaneous drain on wound dehiscence and infection in midline laparotomy for gynecological disease (KGOG 4001) ±è³²°æ(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 08:40~08:50 BRCA µ¹¿¬º¯ÀÌ°¡ ÀÖ´Â ³¼Ò¾Ï ȯÀÚÀÇ À¯¹æ¾Ï À§Çè: Meta-analysis ±è¼¿¬(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 08:50~09:00 IMMUNE CHARACTERISTICS OF TUMOR-INFILTRATING T CELLS IN OVARIAN CLEAR CELL CARCINOMA RELATIVE TO OVARIAN HIGH-GRADE SEROUS CARCINOMA ¹ÚÁؽÄ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 09:00~09:10 Impact of COVID-19 pandemic on Cervical cancer screening - Comparison between healthy women and disabled population; A nationwide study in Republic of Korea Á¤¼ÒÇö(°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 09:10~09:20 Marked impact of preeclampsia on cancer risk: A Nationwide Population-Based Cohort Study ¾î°æÁø(¿¬¼¼ÀÇ´ë ¿ëÀμ¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 09:20~09:30 Endometrial surveillance strategy for detection of tamoxifen-related uterine cancers ¹èÇöÁö(¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 09:30~09:40 Expression and significance of Caveolin-1(Can-1) in Ovarian clear cell carcinoma(OCCC) Á¤ÇÏÀº(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 15:10~15:20 Risk factor for the failure of first-line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: a single- center retrospective study Á¤´ÙÀº(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 15:20~15:30 Bromodomain inhibitor induces cell cycle arrest and apoptotic cell death in epithelial ovarian cancer ±è¿©·¡(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 15:30~15:40 Discrepancy between preoperative tumor marker and imaging outcomes for the predicting ovarian malignancy ±è¼ÒÈñ(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 15:40~15:50 Dyslipidemia is Positively Associated with Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010–2020 À̼±¹Ì(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 15:50~16:00 Prediction for Platinum Resistance of Chemotherapy in Epithelial Ovarian Cancer patients based on Magnetic Resonance Images. ¼ÛÈñ°æ(°¡Å縯ÀÇ´ë ÀÎõ¼º¸ðº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 16:00~16:10 Treatment outcomes and complications in FIGO stage IIIC and IVB endometrioid endometrial cancer patients presenting as nodal spreads following systematic lymphadenectomy and adjuvant therapy µ¿¼ö·Ã(¾ÆÁÖ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 16:10~16:20 Genomic alteration before and after progression on first exposure to PARP inhibitor (PARPi) among ovarian cancer patients undergoing PARPi re-treatment À̰渲(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 16:20~16:30 Role of Klotho and N-acetylcysteine in Oxidative stress associated with the Vitrification of Ovarian tissue À̼±¹Ì(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 16:30~16:40 Transcriptomic Immune Profiles Can Represent the Tumor Immune Microenvironment Related to the Tumor Budding Histology in Uterine Cervical Cancer Á¤°æÈÆ(Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 16:40~16:50 Histopathological evaluation of cervical excision specimen according to age in CIN2 patients ÇöÁ¤¾Æ(°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 16:50~17:00 Laparo-Endoscopic Single-Site versus Conventional Laparoscopic Surgery for Early-Stage Endometrial Cancer; Prospective Randomized Controlled Trial (LESS-E) °¿ÁÁÖ(¿ï»êÀÇ´ë ¼¿ï¾Æ»êº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 17:00~17:10 Pre-treatment neutrophil-to-lymphocyte ratio is associated with improved overall survival in patients with gynecological cancer treated with immunotherapy È«ÁØ¿µ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 17:10~17:20 Clinical implication of P16 immunostaining for prediction of prognosis in young women with moderate cervical dysplasia. À̽¹Ì(°è¸íÀÇ´ë µ¿»êÀÇ·á¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 8 17:20~17:30 Adverse Effects on Overall Survival of Duration of Antibiotics Use Prior to Immune Checkpoint Inhibitors in Patients with Recurrent Gynecologic Malignancies Á¤ÇýÁö(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 08:00~08:10 Microorganisms in human follicular fluid in Endometriosis and Non-endometriosis women ¼ÛÁö¼ö(°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 08:10~08:20 Fallopian tube as a possible modulator associated in the development of endometriosis ¹ÚÇý¹Î(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 08:20~08:30 Development of adeno-associated virus(AAV)-mediated shRNA delivery as a novel gene therapy for endometriosis ÀÌÀç°æ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 08:30~08:40 Estradiol treatment increases M2-like visceral adipose tissue macrophages in obese ovariectomized mice regardless of its anorectic action ³²½ÂÇö(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 08:40~08:50 Digital spatial profiling of endometriosis-derived clear cell and endometrioid carcinomas ¹Ú¿µÈÆ(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 08:50~09:00 Particulate matter(PM) exposures induce adverse effects on endometrium via aberrant apoptotic pathways in vitro and in vivo. Ãß¼ºÇÊ(¿¬¼¼ÀÇ´ë °³²¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 09:00~09:10 Follicular environmental change via HMGB-1 and TLR4 in endometriosis ±èÇýÀÎ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 09:10~09:20 Vitamin D Status and Bone Health in Postmenopausal Women Working in Greenhouses Á¶ÀçÀ±(°æ»ó´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 09:20~09:30 ¸ð¹ÙÀÏ ¾Û ÀڷḦ ÀÌ¿ëÇÏ¿© ºÐ¼®ÇÑ Äڷγª-19 ¿¹¹æÁ¢Á¾°ú ÀÌ»ó ÀÚ±ÃÃâÇ÷ÀÇ °ü°è ±è¼ºÀº(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 09:30~09:40 THE EFFECT OF CATHETER-DIRECTED ETHANOL SCLEROTHERAPY ON OVARIAN RESERVE IN PATIENTS WITH RECURRENT ENDOMETRIOSIS: COMPARATIVE ANALYSIS WITH PRIMARY ENDOMETRIOSIS ÀÌ¿©Áø(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 15:10~15:20 Relationship between hematologic parameters related to systemic inflammation and insulin resistance in women with polycystic ovary syndrome Á¶¹Î°æ(ÀÎÁ¦ÀÇ´ë ÇØ¿î´ë¹éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 15:20~15:30 Leptin Stimulates Endometriosis Development in Obesity ¹è³ª¿µ(°í·ÁÀÇ´ë ±¸·Îº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 15:30~15:40 Determine the impact of different types of SARS-Cov-2 vaccines on IVF outcome ½Å¼Ò¿¬(Â÷ÀÇ°úÇдëÇб³ ºÐ´çÂ÷º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 15:40~15:50 Á¶»ê±â¿Õ·ÂÀÌ ¾ø´Â ¹«Áõ»ó ¿©¼º¿¡¼ Á¶»ê ¿¹ÃøÀ» À§ÇÑ ÀڱðæºÎ ±æÀÌ ÃøÁ¤ÀÇ ÀûÀýÇÑ ½Ã±â ±è¼¼Áø(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 15:50~16:00 Effect of pelvic artery embolization on AMH level in postpartum hemorrhage patients Çö¼ö¹Î(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 16:00~16:10 Obstetric factors associated with non-cephalic presentation in late pregnancy ½ÅÀ¯¹Ì(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 16:10~16:20 The Outcome of Vacuum Assisted Delivery (VAD) : 2007-2022 Experiences in a Single Institution ¹Ú¼ÒÀ±(ÇѸ²ÀÇ´ë °³²¼º½Éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 16:20~16:30 Pregnancy outcomes and obstetrical complications of twin pregnancies with endometriosis: A single center cohort study ÃÖÁö¿¬(Â÷ÀÇ°úÇдëÇб³ °³²Â÷º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 16:30~16:40 The effect of continuous bupivacaine subfascial wound infusion after cesarean delivery ÀÌÁ¤À±(¼¿ï´ëÇб³ ºÐ´çº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 16:40~16:50 Threshold of 50g screening test for gestational diabetes mellitus in twin pregnancy-should it be the same as singleton? ±èÈ¿½Å(Ä¥°î°æºÏ´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 16:50~17:00 ÀÓ½ÅÇÕº´ÁõÀÇ ¿¹Ãø ÀÎÀڷμÀÇ Ç㸮 µÑ·¹ ±è´Ù¿µ(¼¿ï´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 17:00~17:10 The Outcome of Repeat Cerclage in Women with Prolapsed Membrane following Prior Cerclage ŹÇöÁø(ÇѸ²ÀÇ´ë °³²¼º½Éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 17:10~17:20 Àڱ󻸷Áõ°ú ÀÓ½ÅÇÕº´ÁõÀÇ »ó°ü°ü°è: °Ç°º¸Çè½É»çÆò°¡¿ø ºòµ¥ÀÌÅÍ ºÐ¼® ¿¬±¸ ¼Û¸íÀº(¼¿ïƯº°½Ã º¸¶ó¸Åº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 9 17:20~17:30 ÀüÄ¡ÅÂ¹Ý ÀӽźÎÀÇ Å¹ÝÀ§Ä¡¿¡ µû¸¥ Ãâ»ê ÀüÈÄ ÇÕº´ÁõÀÇ ºñ±³ ¾È¼±¾Æ(°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 08:00~08:10 Development and validation of a prediction model for postoperative urinary retention after prolapse surgery ±è¹ÎÁÖ(¼¿ï´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 08:10~08:20 Diagnostic accuracy of retrograde voiding trial for predicting spontaneous voiding function after prolapse and urinary incontinence surgery °í³ªÇö(¼¿ï´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 08:20~08:30 USP10 modulates estrogen receptor in Uterine Adenomyosis °ûÀ翵(À»ÁöÀÇ´ë À»Áöº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 08:30~08:40 External validation of de novo stress urinary incontinence prediction model after pelvic organ prolapse surgery in Korean women ÀÌÀ¯Á¤(¼¿ï´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 08:40~08:50 Lactobacillus probiotics improves dysbiotic vaginal microbiota through gut-vagina-axis in Korean women ¹Ú¼±È(ÀÌÈ¿©ÀÚ´ëÇб³ ÀÇ°ú´ëÇÐºÎ¼Ó ¸ñµ¿º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 08:50~09:00 Endometrium assessment in breast cancer patients with tamoxifen – comparing results from conventional ultrasonography and elastosonography Á¶Çöºó(ºÎ»ê´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 09:00~09:10 The Effect of New Diagnosis-Related Group Payment System on Quality Care and Health Care Cost in the Field of Obstetrics and Gynecology In Korea Á¤¿¬¼ö(±¹¹Î°Ç°º¸Çè°ø´Ü Àϻ꺴¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 09:10~09:20 ±â°èÇнÀ(Machine Learning)À» ÀÌ¿ëÇÑ ¿þ¾î·¯ºí µð¹ÙÀ̽ºÀÇ »ýü½ÅÈ£¿Í ¿ù°æ°ü·Ã Áõ»ó¿¡ µû¸¥ ¿ù°æÁֱ⠿¹Ãø ¹Ú¼±È(¿¬¼¼´ëÇб³ ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 09:20~09:30 Initial experience of Single-port laparoscopic hysterectomy using ArtiSential¢ç wristed articulated needle holder for vaginal vault suture ±è´Ù¿µ(¼¿ï´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 09:30~09:40 Postoperative outcomes of ovarian-preserving surgery in premenopausal women with adnexal torsion ÃÖÀº¾Æ(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 15:10~15:20 »ý¸®¾ç °ú´Ù¸¦ Æò°¡ÇÏ´Â °´°üÀûÁöÇ¥·Î¼ÀÇ »ý¸®´ëÀÇ Ç÷¾×µ¢¾î¸® À¯¹«ÀÇ Á߿伺. Á¤À±¿µ(´ë±¸°¡Å縯´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 15:20~15:30 Continuation of management of ureteral injury after gynecologic surgery – Experience from a tertiary-care institute ¿À¼öÇö(°¡ÃµÀÇ´ë ±æº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 15:30~15:40 Visceral obesity as a risk factor of incisional hernia after single-port laparoscopic gynecologic surgery ±èÁö¾Ö(°¡Å縯ÀÇ´ë ´ëÀü¼º¸ðº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 15:40~15:50 Most uterine fibroids significantly decrease in size spontaneously after delivery È«ÁØ¿µ(¼º±Õ°üÀÇ´ë »ï¼º¼¿ïº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 15:50~16:00 The use of mechanical bowel enema in robotic assisted laparoscopic surgery in gynecology ¹®Áö¼ö(°¡Å縯ÀÇ´ë ÀºÆò¼º¸ðº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 16:00~16:10 Risk factor and incidence of occult malignancy in patients receiving vaginal hysterectomy for pelvic organ prolapse Á¶Á¤¼ö(¿¬¼¼´ëÇб³ ¼¼ºê¶õ½ºº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 16:10~16:20 A retrospective single-center analysis of the 1000 gynecologic robotic-assisted laparoscopic surgery cases ¹ÎÀ±Á¤(°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 16:20~16:30 Predictive factors of Oophorectomy for Adnexal torsion based on clinical and Pathological characteristics: A Single Center Retrospective Study ±è½ÂÈ£(ÇѸ²ÀÇ´ë µ¿Åº¼º½Éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 16:30~16:40 Association osteoporosis and hysterectomy with ovarian preservation: National Health Insurance Database Á¤Èñ¿µ(ÀÎÁ¦ÀÇ´ë »ó°è¹éº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 16:40~16:50 Clinical feature of ectopic pregnancy with massive hemorrhage ¹éÁöÇý(°Ç±¹´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 16:50~17:00 CONSERVATIVE SURGERY FOR DIFFUSE UTERINE LEIOMYOMATOSIS: EXPERIENCE OF 16 CASES OF RADICAL MYOMECTOMY IN A SINGLE CERNTER. ±Ç¼ÒÁ¤(À»Áö´ëÇб³º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 17:00~17:10 Prognostic significance of histological grade in low-risk endometrial cancer ±è»óÀÏ(°¡Å縯ÀÇ´ë ¼ººó¼¾Æ®º´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 17:10~17:20 The efficacy and adverse effects of PARP inhibitor in the treatment of ovarian cancer patient ÃÖº¸¶÷(°¡Å縯ÀÇ´ë ¼¿ï¼º¸ðº´¿ø »êºÎÀΰú)
±³À°½Ã°£ 11-11 Room 10 17:20~17:30 Comparison of Surgical outcomes between Single-port laparoscopic operation and da Vinci single port robotic operation ±èÁ¤¹Î(°í·ÁÀÇ´ë ¾È¾Ïº´¿ø »êºÎÀΰú)